ArticleAnimal models and experimental medicine2026
A rhesus macaque model of α-dystroglycanopathy caused by a POMT1 splice altering variant.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBiallelic mutations in genes associated with α-dystroglycan glycosylation manifest in a spectrum of conditions referred to as α-dystroglycanopathies, including Walker-Warburg syndrome, which primarily disrupt brain, eye, and muscle development. While small-animal models for the disease have been developed and described, the condition has not been documented in non-human primates.
methodsThree spontaneous cases of severe lissencephaly, microphthalmia, and congenital muscular contracture in infant rhesus macaques were investigated. Histological analysis was performed on brain, retina, and skeletal muscle tissue. Genomic sequencing and RT-PCR were used to identify and validate the causative pathogenic variant.
resultsThe genetic basis for disease was determined to be the result of a rare single nucleotide variant altering a canonical splice site in the POMT1 gene. Aberrant splicing was confirmed in affected monkeys and H&E staining demonstrated histological markers consistent with severe α-dystroglycanopathy.
conclusionsRecapitulation of this clinical disease phenotype in a non-human primate establishes the utility of rhesus macaques as a model for dystroglycanopathies, such as Walker-Warburg syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.